| Entry |
|
| Name |
Zatolmilast (USAN) |
| Formula |
C21H15ClF3NO2
|
| Exact mass |
405.0743
|
| Mol weight |
405.79
|
| Structure |

|
| Efficacy |
Phosphodiesterase IV inhibitor |
| Comment |
Primarily for the treatment of cognitive disorders such as Alzheimer's disease and fragile X syndrome
|
| Target |
|
| Pathway |
|
| Brite |
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases (EC3)
Phosphodiesterases
PDE4D
D12173 Zatolmilast (USAN)
|
| Other DBs |
|
| LinkDB |
|
| KCF data |
ATOM 28
1 C6a C 18.4800 -15.6800
2 C1b C 17.2900 -16.3800
3 O6a O 19.6700 -16.3800
4 O6a O 18.4800 -14.2800
5 C8y C 16.1000 -15.6800
6 C8x C 14.9100 -16.3800
7 C8x C 13.6500 -15.6800
8 C8y C 13.6500 -14.2800
9 C8x C 14.8400 -13.5800
10 C8x C 16.1000 -14.2800
11 C1b C 12.4600 -13.5800
12 C8y C 11.2700 -14.2800
13 C8x C 11.2700 -15.6800
14 C8y C 10.0100 -16.3800
15 N5x N 8.8200 -15.6800
16 C8y C 8.8200 -14.2800
17 C8x C 10.0100 -13.5800
18 C1d C 10.0100 -17.7800
19 X F 11.4100 -17.7800
20 X F 8.6100 -17.7800
21 X F 10.0100 -19.1800
22 C8y C 7.6300 -13.5800
23 C8x C 6.4400 -14.2800
24 C8y C 5.1800 -13.5800
25 C8x C 5.1800 -12.1800
26 C8x C 6.3700 -11.4800
27 C8x C 7.6300 -12.1800
28 X Cl 3.9900 -14.2800
BOND 30
1 1 2 1
2 1 3 1
3 1 4 2
4 2 5 1
5 5 6 2
6 6 7 1
7 7 8 2
8 8 9 1
9 9 10 2
10 5 10 1
11 8 11 1
12 11 12 1
13 12 13 2
14 13 14 1
15 14 15 2
16 15 16 1
17 16 17 2
18 12 17 1
19 14 18 1
20 18 19 1
21 18 20 1
22 18 21 1
23 16 22 1
24 22 23 2
25 23 24 1
26 24 25 2
27 25 26 1
28 26 27 2
29 22 27 1
30 24 28 1
|